How to Test for Wilson's Disease

Key Takeaways

• Consider Wilson’s disease in unexplained liver disease before age 40, new neurologic or psychiatric symptoms, or when a first‑degree relative is affected.

• Begin screening with serum ceruloplasmin and a 24‑hour (or random) urinary copper to detect abnormal copper handling.

• Order a slit‑lamp exam to check for Kayser‑Fleischer rings; their presence strongly supports the diagnosis, especially with neurologic features.

• If noninvasive testing is unclear, measure hepatic copper on liver biopsy and consider ATP7B genetic testing.

• Integrate all data using the Leipzig score and refer for genetic counseling and cascade testing of family members when appropriate.

When to Suspect Wilson’s Disease

When should Wilson’s disease be considered? Think about Wilson’s disease in patients with unexplained liver disease—especially before age 40—or with new, unexplained neurologic or psychiatric manifestations. A positive Kayser‑Fleischer ring on slit‑lamp exam strongly supports the diagnosis, particularly in those with neurologic signs. A first‑degree relative with Wilson’s disease should prompt screening and timely evaluation. In children under three, interpret ceruloplasmin with age‑specific reference ranges. Lack of a KF ring or an indeterminate initial workup does not rule out Wilson’s disease; results should be integrated with biochemical testing, the Leipzig score, and targeted genetic testing for ATP7B mutations. Older patients with mixed hepatic and neurologic findings warrant expedited evaluation.

Initial Laboratory Tests to Order

After clinical features or risk factors raise concern for Wilson’s disease, begin with tests that assess copper metabolism and liver function. Measure serum ceruloplasmin first—low levels support the diagnosis but may be less specific in patients with liver disease. A 24‑hour or random urinary copper measures non‑ceruloplasmin (free) copper; elevated values increase diagnostic likelihood. Total serum copper can be normal or low and must be interpreted alongside ceruloplasmin and urinary copper. Obtain basic liver function tests and a comprehensive metabolic panel to evaluate hepatic injury and guide urgency. Early slit‑lamp assessment for Kayser‑Fleischer rings is advised, and reflex testing for ATP7B gene variants is appropriate when biochemical results are suggestive.

Specialized Diagnostic Procedures

Why are specialized procedures sometimes needed? When routine biochemistry is ambiguous, targeted procedures clarify diagnosis. A slit‑lamp exam detects Kayser‑Fleischer rings, which strongly support neurologic presentations. A liver biopsy allows direct measurement of hepatic copper concentration when noninvasive tests and urinary copper are equivocal. ATP7B genetic testing can identify pathogenic variants to confirm or support the diagnosis, especially in familial or atypical cases. Interpret these results together—the Leipzig score combines clinical features, KF rings, liver copper, biochemical data, and ATP7B variants to estimate the probability of Wilson’s disease. Choice of procedures should consider prior test quality, patient age, renal function, and clinical phenotype to avoid unnecessary invasive testing.

Interpreting Test Results and Diagnostic Criteria

How should clinicians integrate laboratory, genetic, and clinical findings to reach a reliable diagnosis of Wilson disease? Use a structured approach that brings together symptoms, biochemistry, ophthalmologic signs, and genetics. The Leipzig score offers a weighted framework but must be interpreted alongside direct evidence. Low ceruloplasmin and elevated 24‑hour urinary copper support biochemical copper overload; increased hepatic copper concentration or visible KF rings strengthen the diagnosis. Identification of pathogenic ATP7B mutations confirms Wilson’s disease, though compound heterozygosity or novel variants may require additional supporting data. Clinical judgment is essential when results conflict or guidelines vary. Key considerations include:

• Combine ceruloplasmin, 24‑hour urinary copper, and hepatic measures rather than relying on a single test.

• Use the Leipzig score as an adjunct, not the sole determinant.

• Confirm ATP7B mutations when possible to secure the diagnosis.

Follow-Up Testing and Genetic Counseling

When should monitoring and genetic counseling start after diagnosis? Begin monitoring and counseling promptly after diagnosis to guide treatment and family evaluation. Follow‑up includes serial ceruloplasmin measurements, repeat 24‑hour urinary copper excretion, liver function tests, and periodic neurologic assessments; repeat hepatic copper quantification only when clinically indicated. Assess treatment response and disease control by trends over time rather than single values, using relevant Leipzig score elements to inform decisions. Genetic counseling should explain autosomal recessive inheritance, the significance of biallelic ATP7B mutations, and options for cascade testing of relatives. Offer carrier testing for close family members and discuss reproductive planning. Coordinate care among hepatology, neurology, and genetics for comprehensive long‑term management.